PPARGC1A and obesity due to melanocortin 4 receptor deficiency: Further study verified that AICAR administration in vivo led to reduced adipose tissue content and improved glucose tolerance and insulin sensitivity in a diet-induced obesity (DIO) mice model, likely through elevating PGC1α expression in adipose tissue and promoting brown/beige adipogenesis [23].